Events

Retiro De Equipo (Recall) de ENDO PEANUT AUTOSUTURE BLUNT DISSECTOR

Según Health Canada (via FOI), este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Canada que fue producido por COVIDIEN.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    17131
  • Clase de Riesgo del Evento
    II
  • Fecha de inicio del evento
    2017-05-11
  • País del evento
    Canada
  • Fuente del evento
    HC
  • Notas / Alertas
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Notas adicionales en la data
  • Causa
    Medtronic is voluntarily recalling specific production lots of the covidien endo peanut blunt dissector 5mm. this voluntary recall is being conducted following reports that the cotton tip of the device may disengage due to insufficient adhesive application during the manufacturing process.

Device

ENDO PEANUT AUTOSUTURE BLUNT DISSECTOR
  • Modelo / Serial
    Model Catalog: 173019 (Lot serial: > THAN 10 CONTACT MFR)
  • Descripción del producto
    ENDO PEANUT AUTOSUTURE BLUNT DISSECTOR
  • Manufacturer
    COVIDIEN

Manufacturer

COVIDIEN
  • Dirección del fabricante
    SAINT-LAURENT
  • Empresa matriz del fabricante (2017)
    Medtronic plc
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    HC